37 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
known to have HIV ... diagnosed with HIV ... and HPV test) is ... IDSA #Prevention #Treatment ... #management #opportunistic
Our approach to the diagnosis and initial management of patients with suspected HIT. Our approach is
diagnosis and initial management ... based primarily on clinical ... laboratory tests ... and to adjust treatment ... #Hematology #HIT
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
Diagnosis: • Clinical ... approach for post-test ... : Confirmatory test ... non-heparin A/C if clinical ... #Treatment #Hematology
HIV PrEP (Pre-Exposure Prophylaxis) - Truvada 

HIV Pre-Exposure Prophylaxis (PrEP) is available in the form of
single once-daily tablet ... meet with their clinician ... & side effect management ... & pregnancy tests ... Truvada #Monitoring #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... mucoadhesive buccal tablet ... chew, or crush tablet ... for effective treatment ... #management #opportunistic
Adult-Onset Still's Disease
Clinical triad: Fever, Arthralgia/arthritis, Skin rash ± odynophagia
+ Biological inflammation: Increased neutrophils, Hyperferritinemia, decreased
Still's Disease Clinical ... Coxsackie, CMV, EBV, HIV ... Disease #diagnosis #management ... #treatment #rheumatology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... Disease Note: Treatment ... and preventing clinical ... #management #opportunistic
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Tuberculin skin test ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... Pathophysiology: 2 hit ... : 33% • Treatment ... : No • Treatment ... diagnosis #comparison #table
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
Related Disease Clinical ... with response to treatment ... specific laboratory tests ... Disease #diagnosis #management ... #rheumatology